Clinical Trial Update: Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the long-term safety and efficacy of the triple CFTR modulator combination Vanzacaftor/Tezacaftor/Deutivacaftor in cystic fibr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Vanzacaftor/Tezacaftor/Deutivacaftor

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: ENROLLING_BY_INVITATION